Innovaccer embraces AI with Humbi AI acquisition
Summary
This marks Innovaccers third acquisition, following Cured and Pharmacy Quality Solutions (PQS) in 2024. "Humbi AIs actuarial expertise complements our existing platform, giving us the unique ability to help healthcare organizations design smarter value-based contracts, optimize drug commercialization, and manage performance in unprecedented ways." In the life sciences sector, the Actuarial Intelligence is expected to help companies optimize drug commercialization through data-driven insights, clinical effectiveness analysis and utilization metrics. Innovaccers embrace of AI mirrors that of health system executives, who plan to invest in artificial intelligence, automation and managed services to improve revenue cycle performance over the next year, according to a September Guidehouse analysis. In March, the Congressional Budget Office addressed AI and machine learning in healthcare, determining that the evidence on the usefulness of the technology is mixed, particularly when it comes to costs.
Classifications
AskAI Classifications
LabelsLinked Companies
